Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitors by Gonzalez Nieto, Daniel et al.
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the 
bidirectional traffic of hematopoietic stem cells and progenitors 
Daniel Gonzalez-Nieto (1,8), Lina Li (1,2), Anja Kohler(3), Gabriel Ghiaur(1), Eri Ishikawa (1,2), 
Amitava Sengupta (1), Malav Madhu (1), Jorden Arnett (1), Rebecca Santho (1), Susan K. Dunn 
(2), Glenn I. Fishman (4), David E. Gutstein (4,5), Roberto Civitelli (6), Luis C. Barrio (7), 
Matthias Gunzer (2), Jose A. Cancelas (1,2). 
(1) Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital 
Medical Center, Cincinnati, OH; (2) Hoxworth Blood Center, University of Cincinnati, Cincinnati, 
OH; (3) Institute of Molecular and Clinical Immunology, Otto von Guericke University, 
Magdeburg, Germany; (4) Leon H. Charney Division of Cardiology, New York University School 
of Medicine, New York, NY; (5) Merck Research Laboratories; (6) Division of Bone and Mineral 
Diseases, Departments of Internal Medicine and Cell Biology and Physiology, Washington 
University School of Medicine, St Louis, 4MO; (7) Unit of Experimental Neurology, Hospital 
Ramon y Cajal, Madrid, Spain; (8) Bioengineering and Telemedicine Group, Center for 
Biomedical Technology, Universidad Politécnica de Madrid, Spain. 
Keywords: Connexin-43, hematopoietic stem cells and progenitors, osteoblasts, osteogenic 
progenitors, stroma, bone marrow. 
ABSTRACT 
Connexin-43 (Cx43), a gap junction protein involved in control of cell proliferation, differentiation 
and migration, has been suggested to have a role in hematopoiesis. Cx43 is highly expressed in 
osteoblasts and osteogenic progenitors (OB/P). To elucidate the biologic function of Cx43 in the 
hematopoietic microenvironment (HM) and its influence in HSC activity, we have studied the 
hematopoietic function in an in vivo model of constitutive deficiency of Cx43 in OB/P. The 
deficiency of Cx43 in OB/P cells does not impair the steady state hematopoiesis, but disrupts 
the directional trafficking of HSC/P between the BM and PB. OB/P Cx43 is a crucial positive 
regulator of trans-stromal migration and homing of both HSC and progenitors in an irradiated 
microenvironment. However, OB/P Cx43 deficiency in non-myeloablated animals does not 
result in a homing defect but induces increased endosteal lodging and decreased mobilization 
of HSC/P associated with proliferation and expansion of Cxcl12-secreting 
mesenchymal/osteolineage cells in the BM HM in vivo. Cx43 controls the cellular content of the 
BM osteogenic microenvironment and is required for homing of HSC/P in myeloablated animals. 
INTRODUCTION 
In the adult bone marrow (BM), the hematopoietic function is supported by the 
proliferation and differentiation of a finite number of transplantable hematopoietic stem cells and 
progenitors (HSC/P) that have self-renewal and multipotential differentiation capacity. Endosteal 
and neighboring vascular/peri-vascular niches have been proposed as anatomic sites that 
control HSC/P activity, providing signals that regulate the stem cell pool size, survival and 
migration1"4. The definition of the cell components of the BM HM is an area of debate. 
Endothelial cells2, mesenchymal stem cells (MSC)5 and osteoblasts and osteogenic progenitors 
(OB/P)1'4,6 represent major cell components of the BM HM. 
A poorly studied mechanism of intercellular communication (IC) in the HM is mediated 
by gap junction (GJ) channels. GJ channels are formed by a large family of proteins called 
connexins (Cx). Each neighboring cell contributes cell-to-cell channels with one hemichannel 
which dock head-to-head. GJ channels have the ability to transfer ions and low-molecular 
weight secondary messengers from one cell to another depending on concentration gradients 
and Cx-dependent selective permeability7. Connexin-43 (Cx43), one of the members of this 
protein family, is highly expressed by adult BM stromal cells 8, by osteoblasts 9, endothelial 
cells2 and MSC5 and is also expressed by HSC10. The presence of a functional Cx43-
dependence of GJIC between osteoblasts and stromal cells, as well as between stromal cells 
and HSC, has been confirmed in vitro11. 
After HSC transplantation, HSC must first home in the BM and then, localize and anchor 
in suitable microenvironments within the BM, a process known as lodgment12. This process 
involves migration of HSC/P through different layers of cell components of the HM, including 
endothelial cells and mesenchymal-origin cells which act as extrinsic HSC/P migration 
regulators13 and is directed by chemokine gradients. Myeloablation through irradiation has been 
postulated to modify the functional ability of the BM HM to allow HSC homing and retention 
through clearance of hematopoietic stem cell niches14. The effect of irradiation on the BM HM is 
not well known but diverse studies have shown that the irradiation of the HM is not ¡nocuous15, 
including the upregulation of expression and secretion of Cxcl12 16 and the upregulation of the 
expression of Cx43 in the BM17. It has been proposed that Cx43 hemichannels are important in 
reinforcing cell-to-cell migration and that Cx43-dependent GJ are needed in the process of 
neuronal migration during neocortex formation18,19. Whether Cx43 expression controls the 
processes of migration of HSC/P within the HM is unknown. 
Here, we analyzed the specific role played by Cx43 in the OB/P HM by using 
conditionally osteoblast-lineage specific Cx43-deficient mice. Our results indicate that OB/P 
Cx43 expression is critical in maintaining the cell composition of the BM osteogenic 
microenvironment and in controlling the content of Cxcl12-expressing cells of the HSC niche 
and the lodging and mobilization of HSC/P in non-myeloablated animals. By contrast, Cx43-
deficiency in an irradiated HM, impairs the homing, trans-stromal migration, radioprotection and 
engraftment of BM HSC. 
MATERIAL AND METHODS 
Animals 
Osteolineage (OB/P)-Cx43-deficient mice were generated by using genetically modified [2.3 Kb] 
Cola1(l)-Cre-Cx43flox/flox mice20. Cola1(l)-Cre mice were crossed with Rosa-loxP-STOP-loxP-
lacZ reporter mice for microanatomical analysis of [3-galactosidase positive cells as previously 
described21. Hematopoietic-Cx43 (H-Cx43) deficient mice were generated using Vav1-Cre-
Qx43fiox/fbx m ¡ c e 22 |n s o m e experiments, we used Mx1-Cre-Cx43flox/flox mice, in which inactivation 
of Cx43 in the whole BM was induced by intraperitoneal administration of double-stranded RNA 
polyl:C (Amersham Pharmacia Biotech, Germany) that promoted interferon production leading 
to the activation of Mx-1 promoter22. Cola1(l)-Cre;WT, Vav1-Cre;WT or polyl:C-treated Mx1-
Cre;WT mice served as controls. Animals were backcrossed for a minimum of five generations 
into C57BI/6 background. UbiquitinC-EGFP mice have been described elsewhere23. Animals 
were bred and housed in the AALAC-accredited animal facility of Cincinnati Children's Hospital 
Medical Center, or purchased from Jackson Laboratories (Ban Arbor, ME). All the experiments 
were carried out under animal protocols approved by the Cincinnati Children's Hospital 
Institutional Animal Committee in conformance with all relevant regulatory standards for animal 
care. 
Analysis of BM cell subpopulations by flow cytometry 
The BM content of HSC/P was immunophenotypically assessed as previously described22. The 
frequency of non-hematopoietic cells containing osteolineage cells and other mesenchymal 
cells was quantified by flow cytometry analysis of CD457Ter119" (APC-CD45, and APC-Ter119, 
e-Bioscience) BM cells. For further quantification of osteolineage cell populations, goat-anti-
mouse cadherin-11 (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and rabbit-anti mouse 
Cxcl12 (Abeam Inc., Cambridge, MA) antibodies were used, followed by incubation with donkey-
anti-goat-PE and donkey-anti-rabbit-PerCP-Cy5.5 (Santa Cruz). After incubation with primary 
and secondary antibodies (Anti-CD45, Anti-Ter119, Anti-cadherin-11 and donkey-anti-goat-PE), 
cells were fixed, permeabilized (Cytofix/Cytoperm, BD), stained with a rabbit-anti mouse Cxcl12 
antibody, and subsequent labeled with donkey-anti-rabbit-PerCP-Cy5.5 antibody as described24. 
All analysis tubes were processed forfixation/permeabilization. Using cadherin-11 as a highly 
expressed marker of osteolineage cells, including osteoprogenitors and nesting hematopoiesis-
supporting MSC5,25, we defined the osteolineage population as CD45", Ter119"and cadherin-
11+, whereas the remaining mesenchymal cells were defined as CD45", Ter119" and cadherin-
11". Gating consisted of a first gate applied to cells stained with an isotype control (to identify the 
CD457Ter119" cell population); a second gate applied to CD457Ter119" cells to analyze 
cadherin-11 expressing populations, based on a preimmune goat serum staining set; and a third 
gate applied to CD457Ter1197cadherin+ or CD457Ter1197cadherin" BM cells to define Cxcl12 
expression based on a control using preimmune rabbit serum. 
Homing assays 
In myeloablated animals: for hematopoietic progenitor homing26, 20x106 BM donor cells were 
injected through the tail vein into lethally irradiated mice (700 + 475 cGy), split doses at a dose 
rate of 58-63 cGy/min; separated 3 hours, and previously demonstrated to eliminate all 
endogenous BM colony-forming-units (CFU-C)27 in control or OB/P-Cx43-deficient recipient 
mice. Sixteen hours after transplant, the recipient mice were sacrificed and the BM cells of the 
lower limbs and pelvis were harvested and cultured in triplicate for CFU-C assay. To estimate 
the BM recovery, we considered that femora, tibiae and pelvis contained 25% of the overall 
BM28. For Lin"/c-kit+/Sca-1+ (LSK) cell homing, 85,000-100,000 sorted BM LSK cells stained with 
carboxyfluorescein succinimidyl ester (CFSE) were transplanted and analyzed27. BM content of 
CFSE+ cells was quantified by flow cytometry. For HSC homing26, 20x106 BM WT CD45.1+ cells 
were injected intravenously into lethally irradiated CD45.2+ WT or OB/P Cx43-deficient primary 
mice. Three hours later, the mice were sacrificed and the BM cells were harvested and injected 
together with 0.5x106 WT CD45.2+ competitor BM cells into secondary lethally irradiated WT 
CD45.2+ recipient mice. The homing percentage was calculated as the ratio between the output 
competitive repopulating units (CRU) from mice transplanted with HSC homed in WT or OB/P 
Cx43-deficient mice, and input CRU. 
In non-myeloablated animals: Homing analysis was performed by transplanting intravenously 
1.9-3.5x107 BM cells from UbiquitinC-EGFP mice into non-myeloablated animals and analyzing 
the femoral and PB content of EGFP+/Lin7c-kit+ and EGFP+/l_in7c-kit7Sca-1+ cells sixteen hours 
after transplantation. This same procedure was also used to analyze the fraction of circulating 
HSC/P in myeloablated animals. Intravital microscopy of HSC/P distribution in the BM of non-
myeloablated animals was analyzed using time-lapse multi-photon intravital microscopy (MP-
IVM, LSM 710 NLO microscope, Zeiss, Germany), with detection by an array of independent 
photomultiplier tube-detectors (non-descanned detectors; NDDs) was used to monitor cells in 
the tibiae of transplanted mice. The cell distance from the endosteal surface immediately 
underneath the endosteal osteoblasts was analyzed29. For imaging, a 300x300 urn area was 
scanned in 30 steps of 4 urn each down to a depth of 120 urn (approximately 12 cell layers) 
using an illumination wavelength of 800 nm and the detection of green (530 nm) fluorescence 
as well as SHG (at 480 nm emission). The 3-D images were used to measured the distance of 
individual cells to the endosteal lining29. 
Engraftment assays 
Radioprotection experiments were performed by transplanting a limiting dose (1x104) of 
congenie CD45.1+ WT BM cells into control or OB/P-Cx43 deficient irradiated recipients. 
Mortality associated with hematopoiesis failure was determined at day 30 post-transplantation. 
For long-term engraftment experiments, 3x105 or 1x106 WT CD45.1+ BM cells were 
administered. The frequency of CD45.1+ cells in PB was followed for up to 14 months. For 
secondary transplantation experiments, 5x106 BM cells were transplanted into lethally irradiated 
C57BI/6 recipients. To determine the content of PB HSC, 400 JLLI of PB from CD45.2+ WT or 
OB/P Cx43-deficient mice were mixed with 5x105 WT CD45.1+ cells as competitors and 
transplanted into lethally irradiated CD45.1+ WT recipient mice. 
Stromal cell isolation, ex vivo expansion and CFU-F/CFU-OB assays. 
BM cells were plated at a density of 6.5 x 105 cells/cm2 on fibronectin-coated wells (Corning 
Inc., NY) in IMDM supplemented with 20% of MSC stimulatory supplements (Stem Cell 
Technologies), 100 umol/L 2-mercaptoethanol, 100 lU/mL penicillin, 0.1 mg/mL streptomycin, 2 
mmol/L L- glutamine, 10 ng/mL human PDGF-BB, and 10 ng/mL rm-EGF. Adherent clusters 
were grown for a minimum of 5 passages. Macrophage depletion was assessed by flow 
cytometry. All experiments were performed on stromal cells in passages 10 through 14. For 
CFU-F, BM cells were plated in the medium mentioned above plus 40% of Methocult (Stem Cell 
Technologies). ForCFU-OB, the same medium was supplemented with 0.1 umol/L 
dexamethasone, 0.25 mmol/L ascorbic acid and 10 mmol/L 2-glycerolphosphate (all Sigma) to 
induce osteoblastic differentiation. All cultures were incubated at 37°C, 5% C02 and 100% 
humidity for 14 days. Adherent cell clusters containing >50 cells were counted as a colonies. 
Osteoblast colonies were detected by alkaline phosphatase activity analysis (Sigma). 
Cxcl12 expression and secretion analysis 
BM Cxcl12 levels were determined in femora crunched in PBS containing a protease inhibitor 
cocktail (Roche Diagnostics, Indianapolis, IN). The cell suspension was spun down. The cell 
pellet and supernatant were processed for lysate (western blot) and extracellular Cxcl12 
analysis (ELISA, R&D Systems, Minneapolis, MN), respectively. In explanted BM stromal cells, 
Cxcl12 expression analysis was performed similarly from stromal cell cultures. Values were 
normalized with respect to the total number of cells in every group and dish. 
HSC/P trans-stromal migration and stromal adhesion 
Migration of hematopoietic progenitors through different types of mesenchymal stromal cells 
was performed by incubation of 5 x 104 LDBM cells derived from control or hematopoietic-Cx43-
deficient animals, on the top chamber of a 24-well transwell plate (Corning) containing a 
monolayer of irradiated (20 cGy) or not irradiated, freshly confluent WT or Cx43-deficient 
stromal cell lines. Recombinant Cxcl12 (100 ng/mL; R&D Systems) was placed in the bottom 
wells, and the 24-well plate was incubated at 37°C, 5% C02. After 16 hours of incubation, cells 
from the bottom chamber were collected by tripsinization, washed in PBS and the number of 
migrated hematopoietic progenitors was determined by CFU-C assay. Adhesion of HSC/P to 
mesenchymal stromal cells was performed by incubation of 5x104 LDBM cells from control or 
Cx43-deficient (derived from H-Cx43-deficient mice) mice on the top of irradiated (20 Gy) freshly 
confluent stromal cells from control or Cx43-deficient (derived from OB/P-Cx43 deficient mice) 
mice cultured previously on 24 well-plates in stromal medium. After one to three hours, non-
adherent cells were removed and incubated for CFU-C assay. All assays were performed in 
triplicate. 
Other Methods are found in Supplementary Methods section. 
RESULTS 
Cx43 deficiency in OB/P Cx43-deficient mice does not impair steady-state hematopoiesis. 
We have previously demonstrated that Cx43-deficiency in fetal liver stromal cells 
induced hematopoietic failure, using in vitro cobblestone-area-forming-cell (CAFC) assays8. 
Here, we analyzed whether Cx43 was required in osteogenic lineage cells, major cellular 
constituents of the BM stroma, to support hematopoiesis in vivo. We evaluated the effect of 
constitutive loss-of-function of Cx43 in these cells, using collagen type 1, alpha 1 (Col1-a1)-
Cx43flox/flox mice, which had been shown to induce osteoblast functional deficiency20. Cre 
recombinase expression driven by the Collal promoter induced gene excision in osteocytes 
(located in the cortical bone) and in cells on or near the endosteal surface but not in multilineage 
hematopoiesis within the BM cavity (Fig. S1A). Using cadherin-11, a highly expressed marker of 
osteolineage cells, including osteoprogenitors and nesting hematopoiesis-supporting MSC5,25, 
we found that the expression of Cx43 was ~4-log diminished in BM OB/P cells, phenotypically 
defined as CD457Ter1197Cadherin-11+, derived from Col1-a1-Cre;Cx43flox/flox mice compared to 
control but not in other HM cell constituents (CD457Ter1197Cadherin-11", Fig. S1B). Cx43 
immunoblots revealed a drastic reduction in Cx43 protein expression in BM CFU-F from Col1-
a1-Cre;Cx43fl0X/fl0X mice (Fig. S1C) due to Cx43 gene deletion (Fig. S1D). Cx43 RNA and 
protein expression were also abolished in explanted macrophage-depleted stromal cells from 
the BM of Col1-al-Cre;Cx43flox/flox mice (Fig. S1E-F). Thus, Col1-a1-Cre;Cx43flox/flox mice have a 
severe deficiency of Cx43 in the BM OB/P and explanted stromal cells, well recognized cell 
constituents of the HM. 
The Col1-a1-Cre;Cx43flox/flox (OB/P Cx43-deficient) mice demonstrate normal 
hematopoiesis in young mice (8-20 week-old). The BM content of hematopoietic progenitors 
and immunophenotypically identified HSC of OB/P Cx43-deficient is similar to BM from WT mice 
(Fig. 1 A-C), suggesting that the loss of function of Cx43 in BM osteogenic cells does not change 
steady state hematopoiesis or the content of phenotypically identified HSC/P in primary mice. 
Engraftment of WT HSC into OB/P Cx43-deficient HM is impaired through a homing 
defect. 
HSC activity is characterized by their self-renewal ability in repopulation experiments 
where they rescue lethality after myeloablation. To evaluate the contribution of Cx43 in the HM 
to mediate HSC engraftment and repopulating efficiency, we analyzed the hematopoietic 
function of CD45.2+WT or OB/P Cx43-deficient mice transplanted with different doses of 
CD45.1+WT cells. A limiting cell dose as low as 1x104 erythrocyte-lysed WT BM cells, rescued 
50% of WT recipient mice, whereas all OB/P Cx43-deficient recipient mice died between Day 8 
and Day 18 post-transplantation (p<0.01, Fig. 1D). When the two groups of recipient mice were 
transplanted with a larger dose of 3x105 WT BM cells, both, WT and OB/P Cx43-deficient 
recipients remained alive for more than 8 months with no differences in survival (data not 
shown), however, the long-term competitive repopulation was severely reduced in the OB/P-
Cx43-deficient mice compared to the controls (p<0.01, Fig. 1E). Chimerism levels of WT and 
OB/P Cx43-deficient recipient mice transplanted with a higher dose of WT BM cells (1x106), 
remained >95% for up to 14 months, and did not significantly differ between the WT and OB/P 
Cx43-deficient mice (data not shown). 
To define the significance of Cx43-HM expression in long-term (LT)-HSC function, we 
transplanted BM from control or OB/P Cx43-deficient primary recipient mice (which had 
received 1 x 106 BM CD45.1+ cells in the primary transplant), into lethally irradiated secondary 
CD45.2+ WT recipients. As mentioned before, in the primary recipients normal short-term (ST, 4 
week) and LT (14 month) chimerism was seen in WT HSC from either the WT or OB/P Cx43-
deficient HM (data not shown). However, secondary recipient mice transplanted with WT HSC 
that had previously resided in OB/P Cx43-deficient HM for 14 months showed increased 
mortality during the second month post-transplantation (p<0.05, Fig. 2A). Death was due to 
pancytopenia in the presence of BM hypocellularity, loss of splenic follicle architecture, and 
severely diminished PB counts (Fig. 2B-E, S2A). Analysis of the BM compartment in the 
secondary recipient mice on Day 71 after secondary transplantation (Fig. 2A, pink arrow), 
showed a reduction in total BM cellularity (188.9±10.1 x 106 BM cells in secondary recipients of 
WT BM engrafted in WT primary recipients versus 48.6±13.8 x 106 BM cells in secondary 
recipients of WT BM engrafted in OB/P Cx43-deficient primary recipients; p<0.01), together with 
a dramatic reduction in the engraftment of CD45.1+ BM donor cells which had previously 
resided in the OB/P Cx43 deficient mice (Fig. 2F). The reduced engraftment involved both 
myeloid and lymphoid populations (Fig. S2B), and a dramatic reduction in the BM content of 
donor LK (Fig. 2G) and LSK hematopoietic cells (Fig. 2H). These data strongly indicated that 
the long-term WT hematopoietic graft in OB/P Cx43-deficient primary recipient mice was 
deprived of radioprotection and serial repopulation ability due to an extrinsic defect in the HM of 
OB/P Cx43-deficient mice. 
To explore the mechanism associated with the engraftment defect, we performed a 
homing assay of WT BM cells into lethally irradiated OB/P-Cx43-deficient or control recipient 
mice. Under these experimental conditions, there was an around 60% reduction in the ability of 
the WT hematopoietic progenitors to home into irradiated Cx43-deficient BM compared to 
control mice (Fig. 3A). Similar to what has been shown in other models of defective homing of 
HSC30, this homing defect did not translate into an increase of the fraction of circulating WT 
HSC/P in OB/P Cx43-deficient mice, as assessed by their immunophenotype Lin7c-kit+/Sca-1+ 
(LSK) and Lin7c-kit+/Sca-1" (LK+S") at 16 hours post-transplantation (Fig S2C). The deficiency of 
Cx43 in the HM not only compromises the homing efficiency of hematopoietic progenitors but 
also the HSC population, since the long-term competitive repopulating units populations showed 
reduced homing in OB/P Cx43-deficient mice (Fig. 3B). We then tested whether the homing 
defect could be attributable exclusively to a Cx43-deficiency in the OB/P compartment from birth 
(OB/P mice model) ora Cx43 deficient HM induced during adulthood (Mx1-Cre mice model). In 
Mx1-Cre;Cx43fl0X/fl0X macrophage-depleted, BM stromal cells, Cx43 expression was practically 
abrogated (Fig. S3C). The homing of WT hematopoietic progenitors was similarly impaired in 
Mx1-Cre mice where the BM HM was Cx43-deficient (Fig. 3C). Curiously we did not find a 
homing defect when Cx43 was specifically absent from hematopoietic progenitors (from Vav1-
Cre-mice, compare dashed bar with empty bars in Fig 3C), indicating the exclusive dependence 
of Cx43 in the HM mediating the homing process in myeloablated animals. Altogether, these 
data indicate that the BM homing HSC/P is severely reduced in Cx43-deficient irradiated HM, 
and specifically is impaired in OB/P Cx43-deficient mice. 
HM Cx43 deficiency impairs the migration of hematopoietic progenitors through 
irradiated stroma. 
We analyzed the cellular mechanism of the homing defect induced by deficiency of Cx43 
in the HM. We hypothesized that OB/P Cx43 deficiency may result in defects in the HSC/P 
migration through Cx43-deficient HM as it has been shown in neural migration along radial glia 
during development18,19. We studied the capacity of Cx43-deficient stromal cells to support the 
migration of HSC/P in vitro (Fig. 3D). In this novel assay, similar to trans-endothelial migration 
assays, we analyzed the ability of HSC/P to migrate through irradiated stromal cells towards a 
gradient of Cxcl12. This assay intends to model the physiological migration of HSC/P through a 
subendothelial layer of irradiated stromal cells. There was a reduction of approximately 50% in 
the migration of WT hematopoietic progenitors through BM Cx43-deficient, macrophage-
depleted stromal cell propagated explants (Fig. 3E). The trans-stromal migration of Cx43-
deficient HSC/P (Fig. 3F) was reduced and similar to the migration of WT progenitors through 
Cx43-deficient stromal cell lines (compare Figs 3E and 3F). This reduction in the migration of 
WT HSC/P through OB/P Cx43-deficient BM stroma was not associated with a reduction in firm 
adhesion (Fig. S2D), suggesting that firm adhesion of HSC/P is not mechanistically responsible 
for the defective trans-stromal migration of HSC/P through OB/P Cx43-deficient stroma. 
To discern whether Cx43 expression specifically controls the trans-stromal migration of 
HSC/P, we expressed rat Cx43 cDNA in Cx43-deleted macrophage-depleted stromal cells 
which were obtained from OB/P Cx43-deficient mice (induced during fetal development). 
Although the transduction of rat Cx43 cDNA into Cx43-deficient cells derived from OB/P Cx43-
deficient mice (Fig S3A) restored cell-to-cell dye transfer (data not shown), it did not restore 
their trans-stromal migration ability (Fig. S3B). In contrast to the ineffectiveness of Cx43 
reintroduction to restore the migration of HSC/P through OB/P Cx43-deficient stromal cell lines, 
exogenous Cx43 expression in Mx1-Cre; Cx43-deficient stromal cells (Fig. S3D) did restore 
both cell-to-cell calcein transfer (Fig. S4A-D) and trans-stromal migration of WT HSC/P (Fig. 3G, 
dashed bar), suggesting that the deficient migration of WT HSC/P through Cx43-deficient 
stroma may be a result of an irreversible modification in the cell composition of the BM HM in 
vivo. 
Cx43 expression in the OB/P HM controls HSC/P lodgment, retention and mobilization in 
non-myeloablated animals. 
All the experiments in OB/P Cx43-deficient animals or stroma shown above were 
performed after irradiation of the HM. In fact, Cx43 expression has been shown to be 
upregulated up to 80-fold in the BM of irradiated animals17. We hypothesized that Cx43 
upregulation during irradiation may represent a determinant of HSC homing and that could differ 
from the Cx43 contribution to the homing and/or retention of HSC/P in the OB/P niche in non-
myeloablated conditions. We performed a group of experiments directed to analyze the homing 
and retention of HSC/P in non-myeloablated OB/P Cx43-deficient animals. 
We, first, analyzed the content of circulating HSC/P in OB/P Cx43-deficient mice and, 
found that the number of circulating hematopoietic progenitors (assessed by a CFU-C assay) 
was diminished by -30% in the OB/P Cx43-deficient mice compared with WT mice (Fig. 4A). 
This finding was confirmed at the HSC level by transplantation of blood from WT or OB/P Cx43-
deficient animals in a competitive repopulation assay, where WT mice transplanted with PB 
from OB/P Cx43 deficient mice showed a -60% reduction in the content of circulating 
competitive repopulating cells compared with control mice (Fig. 4B). There were no differences 
between WT and OB/P Cx43-deficient mice in the content of hematopoietic progenitors in the 
spleen (Fig. S5A), suggesting that the reduction of circulating HSC/P may associate exclusively 
with the increased retention of HSC/P in the BM osteogenic HM. Furthermore, Cx43-deficient 
mice treated with G-CSF do not mobilize as well as WT animals (Fig. 4C) and show higher 
HSC/P numbers in BM after G-CSF administration (Fig. 4D).Correlating with the higher retention 
of HSC/P within a HM-Cx43-deficient, non-irradiated recipient OB/P Cx43-deficient mice 
receiving BM from Cx43 WT, ubiquitinC-EGFP transgenic congenie animals showed fewer 
circulating HSC/P (LSK and LK+S") cells in the PB compared with WT counterparts at 16 hours 
post-transplantation (Fig. 4E). While the organ homing of WT HSC/P in OB/P Cx43-deficient 
mice was unaltered (Fig. S5B), the lodgement of fluorescently-labeled WT hematopoietic 
progenitors into non-myeloablated recipients, followed by in vivo multiphoton microscopy24,29 
showed that the distance between the transplanted HSC/P and the endosteum was significantly 
smaller in OB/P Cx43-deficient tibiae (23.2 ± 0.9 urn versus 34.3 ± 6.8um, respectively, p<0.01; 
Fig. 4F-G). Contrary to the deficient migration of HSC/P through irradiated Cx43-deficient 
stroma, the migration of HSC/P through Cx43-deficient, non-irradiated stroma was pemissive for 
HSC/P migration (Fig. S5C). These results indicate that Cx43 gene deletion in the non-
myeloablated BM OB/P compartment perturbs the endosteal lodging, retention and mobilization 
of HSC/P and suggest the existence of an alternative mechanism of HSC/P lodgment and 
retention dependent on OB/P Cx43 expression. 
OB/P Cx43 deficiency results in in vivo expansion of Cxcl12-expressing BM cells and 
increased level of Cxcl12 in the BM of non-myeloablated mice. 
The retention of HSC/P relates to their ability to respond to chemoattractant gradients, 
which induce HSC/P retention in specific regions within the BM HM. OB/P express and secrete 
the BM chemoattractant Cxcl12, which is a crucial molecule mediating the retention and homing 
of HSC/P31"33. The binding of Cxcl12 to its receptor Cxcr4 provides signals that regulate the 
adhesion and interaction of HSC/P within specific niches in the subendosteal region (reviewed 
in 34). 
To analyze whether a change in the level of Cxcl12 is related to the higher retention of 
HSC/P in the BM of OB/P Cx43-deficient animals, we first analyzed the BM levels of Cxcl12 in 
vivo. We observed that both overall expression (Fig. 5A) and extracellular Cxcl12 levels (Fig. 
5B) were significantly increased in the BM of unchallenged OB/P Cx43-deficient mice compared 
with BM from control mice. These results were also confirmed in three different stromal cell lines 
derived from OB/P Cx43-deficient mice. The expression and secretion of Cxcl12 was nearly 10-
fold increased in these stromal cells compared with stromal cell lines derived from WT animals 
(Figs. S5D-E). Interestingly, while BM myeloablation increased the BM extracellular level of 
Cxcl12 in WT mice, it fails to do so in OB/P Cx43-deficient mice (Fig. 5B). The increased 
expression and secretion of Cxcl12 of non-myeloablated OB/P Cx43 deficient animals was 
maintained after administration of G-CSF (Fig. 5C-D), a HSC mobilizer able to significantly 
decrease the level of BM Cxcl1233. 
OB/P Cx43-deficient animals show osteogenic defects since birth20. We hypothesized 
that OB/P Cx43 deficiency results in a modified cellular composition of the BM mesenchymal 
cell populations in vivo that could be related with the observed increasing Cxcl12 levels. 
Therefore, we analyzed first the content of mesenchymal progenitors (CFU-F), osteoblastic 
progenitors (CFU-OB) and other osteogenic-lineage cells in the BM of OB/P Cx43-deficient 
mice. A 2- and 3-fold increase in the number of CFU-F (Fig. 6A) and CFU-OB (Fig. 6B) was 
observed, indicating that Cx43 deficiency induces a significant expansion of the mesenchymal 
and osteoprogenitor compartment in the BM. The increase in non-hematopoietic cells in the 
marrow was confirmed by a quantitative flow cytometry analysis of Cxcl12-expressing, CD45" 
/Ter119" BM cells in OB/P Cx43-deficient mice. Quantitative analysis of non-hematopoietic 
subpopulations revealed an approximately 2-fold increase in the content of non-osteogenic 
mesenchymal CD457Ter-1197cadherin-11" cells (Figs. 6C-D), whereas the pool of OB/P cells 
(CD457Ter-1197cadherin-11+) in the BM was not significantly changed (Fig. 6E). The frequency 
of Cxcl12-expressing cells in OB/P Cx43-deficient BM was increased in the CD457Ter119" 
/cadherin-11+ cell fraction and, even more, in the CD457Ter1197Cadherin-11" cell population 
(approximately 2- and 3.5-fold respectively; Figs. 6F-G) indicating that OB/P Cx43-deficient 
mice contained a larger fraction of Cxcl12-expressing HM cells within both osteogenic and non-
osteogenic fractions. This expansion of Cxcl12-expressing mesenchymal cells was due to 
increased proliferation in vivo (Figs. 6H-I) and is associated with -90% decreased levels of 
sclerostin (Sost) expression (Fig. 6J), an osteocyte-expressed hormonal negative regulator on 
MSC and osteoprogenitor proliferation35. 
Altogether, our data indicate that OB/P Cx43 is indispensable to allow HSC homing in 
irradiated recipients and acts as a regulator of HSC traffic in and out of the stem cell niche, 
directly through impaired migration through irradiated HM and indirectly through control of the 
BM Cxcl12-expressing cell composition. The deficiency of Cx43 in OB/P induces a quantitative 
and functional changes in the HM related to its ability to allow bidirectional trafficking (homing 
and mobilization) of HSC/P and increased content of Cxcl12-expressing mesenchymal cells. 
DISCUSSION 
The specific cellular microenvironment in which HSC reside within the BM cavity, termed 
a "niche" is required for correct HSC function under basal and stress conditions. A complex 
interplay of cytokines, chemokines, proteolytic enzymes, and adhesion molecules maintain 
HSC-anchorage to the niche infrastructure. A generic group of mesenchymal-lineage stromal 
cells, encompassing osteoblasts4,6, N-cadherin+ pre-osteoblastic cells 36, CAR cells 3, 
osteoblastic progenitors37 and so-called MSC (MSC)5, have been shown to play a signaling role 
in the control of the composition and function of HSC niches. 
In HSC transplantation, for a successful engraftment, the transplanted HSC must first 
home in the BM and then, localize and anchor in suitable microenvironments within the BM, a 
process known as lodgment12. While the fate of non-lodged HSC/P is unclear, a fraction of BM 
HSC/P may not survive while another cell fraction may circulate in PB through a highly 
regulated process of HSC traffic. 
Our understanding of the HM in relation with HSC traffic has significantly advanced. The 
HM is connected through the sympathetic nervous system38 which controls the expression and 
release of Cxcl12 through the stimulation of pyadrenergic receptors in stromal cells5, and 
therefore modulates the migration of HSC/P. Postganglionic sympathetic fibers in the BM are 
associated with blood vessels, and adventitial reticular cells connected by GJ, together form a 
pseudosynchytial structural network. GJ-like structures in the BM were identified 30 years ago39, 
and the first functional relationship between GJ structures and the HM was seen in the 
increased numbers of GJ structures in the stromal cells of stromal-dependent stem cell factor-
deficient (Sl/Sld) mice40. 
Cx43 has been shown to be the predominant Cx in BM stromal cells and in 
osteoblasts41, and is also expressed by HSC10. A latent network of Cx43-dependent GJIC in 
normal quiescent marrow has been proposed, which may be upregulated in neonatal marrow or 
after forced stem cell division17. Outside of the BM, the deficiency of Cx43 has been shown to 
induce increased cell proliferation in vitro and in vivo, through the loss of its tumor suppressor 
functions 42,43,and to regulate the migration of neural progenitors in contact with radial glia 
during brain development18,19. 
Using a murine model, in which Cx43 deficiency was specifically induced in osteoblasts 
and osteoprogenitors, we studied the function of Cx43 in the process of HSC/P migration in 
steady-state conditions and after transplantation in myeloablative and non-myeloablative 
conditions. We found that the deletion of Cx43 in HM produces several, distinct short- and long-
term effects on HSC/P migration and hematopoietic function, which probably are related with 
different functions exerted by this connexin in the BM. 
The attributed Cx43 function as a regulator of cell migration in other non BM tissues, led 
us to analyze whether Cx43 could mediate the migration of HSC/P. We analyzed the homing of 
HSC/P in myeloablative conditions, which significantly upregulate the expression of Cx4317 and 
Cxcl1216 expression in the BM HM. Homing of progenitors and repopulating stem cells was 
defective in myeloablated OB/P Cx43-deficient mice as assessed by defective homing assays 
for both functional hematopoietic progenitors and competitive repopulating cells. The defective 
homing in myeloablated animals is biologically relevant since it results in both radioprotection 
failure and long-term HSC engraftment failure of WT HSC transplanted into OB/P Cx43-deficient 
recipients. The homing defect correlates with defective in vitro trans-stromal migration. The 
mechanism responsible for the migration defect does not require the expression of Cx43 by 
HSC/P, indicating that the Cx43-dependent heterocellular interaction between HSP/C and 
stromal cells is not implicated in this process. These results agree with our previous findings, 
which showed that irradiated stromal Cx43-deficiency impaired formation of CAFC8, a 
surrogate assay for HSC/P function which depends on trans-stromal migration and provide in 
vivo and cellular mechanistic analysis of the defects associated to the hematopoiesis of Cx43-
deficient BM. Rescue of metabolic coupling, a crucial function of Cx43 in GJIC, and rescue of 
trans-stromal migration of HSC/P, through re-expression of Cx43 in inducible Cx43-deficient BM 
stromal cells indicated that, the function of mesenchymal cells from inducible, short-term, Cx43-
deficient BM, but not from long-term OB/P Cx43-deficient BM, can be restored . We 
hypothesized that the OB/P Cx43-deficient BM cell composition may be responsible for the lack 
of restoration of trans-stromal migration after Cx43 reintroduction. 
On the other hand, we found that an OB/P Cx43-deficient microenvironment cell 
composition was significantly modified compared with WT mice. These mice showed an overall 
expansion of mesenchymal cells, including Cxcl12-expressing cells, which translates into 
increased levels of expression and secretion of Cxcl12 within the BM basally and after G-CSF 
administration. The expansion of mesenchymal/osteogenic progenitors with an increased ability 
to express and secrete Cxcl12 may be explained as a result of the decreased expression and/or 
secretion of one or several short-distance acting factors with inhibitory activity on the 
proliferation of bone-forming progenitor cells. Among them, the expression level of sclerostin44, 
an osteocyte-expressed hormonal negative regulator on MSC and osteoprogenitor 
proliferation35 was found to be downregulated in OB/P Cx43-deficient mice, correlating with the 
increased BM content of osteoprogenitors. 
BM Cxcl12 controls the migration of HSC/P between the BM and circulation33, and 
mesenchymal-lineage cells, including mesenchymal progenitors and osteolineage cells, act as 
cell effectors of Cxcl12 secretion5,31.The increased level of Cxcl12 expression and secretion 
induced by the long-term deficiency of osteolineage Cx43 in non-myeloabled BM overrides the 
homing and impaired trans-stromal migration found in myeloablated mice or stroma, suggesting 
that OB/P Cx43 functions as a homing factor only in irradiated animals. Accordingly, we found a 
decreased number of circulating HSC/P (assessed by both progenitor and competitive 
repopulating assays) in non-myeloablated OB/P Cx43-deficient mice in parallel with a reduced 
level of circulating HSC/P, suggesting a higher retention of HSC/P in the BM. Such a phenotype 
correlated with a significantly closer location of HSC/P to the endosteum of OB/P Cx43-deficient 
bones but not with increased BM homing or trans-stromal migration, suggesting the existence of 
an extrinsic mechanism controlling the microanatomical location of HSC/P in OB/P Cx43-
deficient mice. Both decreased circulation of HSC/P and closer location of HSC/P to the bone 
endosteum were related with normal HSC/P trans-stromal migration and increased Cxcl12 
expression and secretion by the HM of non-myeloablated OB/P Cx43-deficient mice. Increased 
Cxcl12 expression levels were likely due to increased BM content of Cxcl12-expressing 
mesenchymal cells and osteoprogenitors. Recently it has been demonstrated that Cxcl12 
secretion is diminished in BM stromal cells when GJIC is impaired by the non-specific drug 
carbenoloxone45. A reduction in Cxcl12 secretion was also observed in vitro by using specific 
shRNA against Cx43 in stromal cells with previous Cx45 deficiency in their genetic 
background45. In contrast, it has been demonstrated that intercellular GJ channels in the BM 
stroma permit the transfer of small non-coding RNA as miR-197, an microRNA interfering 
Cxcl12 expression, a phenomenon which can be relevant in physiological and pathological 
conditions46. Our model of OB/P Cx43 deficiency indicates that Cxcl12 secretion is highly 
dependent on the cellular context. After myeloablation in vitro or in vivo, the levels of Cxcl12 in 
WT BM increase as previously reported16 while the OB/P Cx43-deficient BM Cxcl12 levels 
remain at the same level as in non-myeloablated animals, eliminating the difference in Cxcl12 
expression and secretion between WT and OB/P Cx43-deficient BM. The mechanism of the 
lack of overproduction of Cxcl12 by OB/P Cx43-deficient BM after myeloablation is unclear but 
may have to do with the described intrinsic role of Cx43 on Cxcl12 secretion45. Therefore, our 
experiments clearly indicate that the deficiency of Cxcl12 secretion induced by Cx43 deficiency 
is observed after myeloablation but not in steady-state conditions. 
This data establishes the role of Cx43 as a positive regulator of homing and engraftment 
in myeloablated recipients, reinforces the role of Cxcl12-expressing osteoprogenitors and 
mesenchymal cells as major constituents of the BM stem cell niche and presents Cx43 as an 
indirect negative regulator of endosteal homing in non-myeloablated animals. A defective "soil" 
induced by Cx43-deficiency would be responsible for the bidirectional trafficking defect of HSC 
in Cx43-deficient BM. 
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FIGURE LEGENDS 
Figure 1. Cx43 deficiency in OB/P compartments does not modify steady-state 
hematopoiesis but impair radioprotection in primary recipient mice (A) BM cellularity (2 
femora, 2 tibiae and pelvis) in WT and OB/P Cx43-deficient mice. (B) BM content of HSC/P 
subpopulations in WT and OB/P Cx43-deficient BM. (C) Hematopoietic progenitor content 
(CFU-GM, BFU-E and CFU-Mix) in the BM of WT and OB/P Cx43-deficient mice. (D) Survival 
curve of lethally irradiated WT (dashed line) or OB/P Cx43-deficient (solid line) recipient mice 
transplanted with 1x104 WT BM cells (low dose). (E) Percentage of chimerism in WT (empty 
circles) and OB/P Cx43 deficient mice (solid circles) transplanted with 3x105 WT CD45.1+ BM 
cells. Data are shown as mean ± SEM, of two independent experiments, with a minimum of 7 
mice per group 
Figure 2. OB/P Cx43 expression is required for progenitor-dependent radioprotection and 
serial transplantation engraftment of WT HSC. (A) Survival curve of secondary recipients of 
WT hematopoiesis from WT (dashed line) or OB/P Cx43-deficient primary recipients (solid line), 
which had been transplanted with 1x106 WT BM cells (high dose). BM from primary recipient 
mice were pooled and transplanted into secondary recipients and analyzed. The remaining 
secondary recipient mice were sacrificed on Day 71 after transplantation and the experiment 
was terminated (arrow). (B) Representative micrographs (O.M. x10) of longitudinal femoral 
sections (hematoxylin/eosin staining) of WT in WT secondary recipients and WT in OB/P Cx43-
deficient secondary recipients. (C-E) PB counts of control and WT hematopoiesis in OB/P Cx43-
deficient secondary recipients on Day 71 after transplantation. Empty bars represent data from 
WT controls; solid bars represent data from secondary recipients of WT hematopoiesis into 
OB/P Cx43-deficient hematopoiesis in primary recipients. (F-H) Quantification of BM cell 
populations from secondary recipients receiving WT chimeric BM from a primary recipient HM 
that was either WT (empty bar) or OB/P Cx43-deficient HM (solid bar). (F) Total CD45.1+ BM 
cellularity. (G) CD45.1+ LK BM cells. (H) CD45.1+ LSK BM cells. Values shown are mean ± 
SEM. n > 5 mice per group (**p< 0.01). 
Figure 3. BM homing of WT hematopoietic progenitors is impaired in myeloablated OB/P 
Cx43-deficient mice. Impaired migration of HSC/P through irradiated Cx43-deficient 
stromal cell lines in a vitro assay. (A) Homing of BM CFU-C in the BM of either irradiated 
control (empty bar) or OB/P Cx43-deficient (solid bar) recipient mice at 16 hours post-
transplantation. A dramatic reduction in the ability of HPC to home into the BM was seen when 
Cx43 is not expressed in the HM. (B) HSC homing assay in WT or OB/P-Cx43 deficient mice. 
Graph represents homing (%) after 3 hours post-transplantation of competitive repopulation 
units analyzed 20 weeks post-transplantation into congenie recipients. The secondary recipients 
were injected with BM cells from primary WT or OB/P Cx43 deficient recipient mice that had 
been previously transplanted with WT 25x106 CD45.1+ BM cells. Harvesting of BM cells from 
primary recipients was performed 3 hours after transplant. (C) Similarly to OB/P Cx43-deficient 
mice, homing of WT CFU-C to the BM of polyl:C treated Mx1-Cre-Cx43flox/flox mice is drastically 
reduced compared to homing of either WT or Cx43-deficient HSC/P into Mx1-Cre;WT mice at 
16 hours post-transplantation. Data represent n=4 independent experiments with 5 mice per 
group and experiment. (D) Experimental scheme of the trans-stromal migration assay. LDBM 
cells were incubated on a monolayer of BM stromal cells previously layered on a transwell 
membrane. A Cxcl12 gradient was established from bottom to top of the transwell. (E-F) Trans-
stromal migration of WT (E) or Cx43-deficient (F) HSC/P through WT or Cx43-deficient stromal 
cells. Migration of WT or Cx43-deficient HSC/P was similarly impaired when assayed in 
presence of WT or Cx43-deficient stromal cells. (G) Trans-stromal migration was restored upon 
reintroduction of rat-Cx43 expression (grey bar) into Cx43-deficient stromal cell lines. Results 
from WT controls (empty bars) and mock-transduced, Mx1-Cre;Cx43-deficient stromal cells 
(solid bar) are also depicted. Data for homing experiments are shown as mean ± SEM, of three 
independent experiments, with a minimum of 7 mice per group. Data for trans-stromal migration 
are shown as mean ± SEM. n=4 independent experiments. (* p<0.05; **p < 0.01; *** p<0.001; # 
p=0.08). 
Figure 4. HSC/P are retained basally or after G-CSF administration, and located closer to 
the endosteum in the BM of OB/P Cx43-deficient mice. (A) PB CFU-C counts in WT (empty 
bar) and OB/P Cx43 deficient mice (solid bar). N=4 independent experiments, n=5 mice per 
group. (B) Percentage of chimerism in WT CD45.1+ lethally irradiated recipient mice which were 
transplanted with a mixture of 5x105 WT CD45.1+ BM cells (competitor cells) and 400 |iL PB 
from CD45.2+ WT or OB/P Cx43-deficient donors. N=2 independent experiments, n=5 mice per 
group. (C) Count of circulating HSC/P after G-CSF administration in WT and OB/P Cx43-
deficient mice. N=3 independent experiments, n=5 mice per group. (D) Hematopoietic 
progenitor content of BM of G-CSF treated WT and OB/P Cx43-deficient mice. N=3 
independent experiments, n=5 mice per group.(E) Non-irradiated WT or OB/P Cx43-deficient 
mice were transplanted with WT BM-EGFP+ cells. Percentage of EGFP+ LSK and LK+S" cell 
populations, determined by flow cytometry, in the PB at 16 hours post- transplant. N=2 
independent experiments, n=7-8 mice per group. (F-G) In vivo imaging using multiphoton 
microscopy technique of transplanted carboxyfluorescein-labeled hematopoietic progenitors (LK 
BM cells average n>25) clustered closer to the endosteum in OB/P Cx43-deficient mice than in 
controls (empty circles) (n=2 independent experiments). HSC/P were stained with CFSE directly 
after isolation and transplanted into WT or OB/P Cx43-deficient mice. After 24 h intravital 
multiphoton imaging was performed in the tibiae of the recipient animals, (i) HSC/P (displayed in 
green) located distantly from the bone (brown, detected by its SHG signal) in the tibia of a WT 
recipient, (ii) Additionally the blood vessels could be detected after an i. v. injection of 
rhodamine-dextran (displayed in red). The dimensions of the original Z-Stack were: X =85.53 
|im, Y =85.53 |im; z =108 |im. The image resolution (XYZ) was 512 x 512 x 28 |im. The pixel 
size was 0,167 |im in x and y and 4 |im in z. (iii) HSC/P (displayed in green) in close contact to 
the endosteum (brown, detected by its SHG signal) in the tibia of an OB/P Cx43-deficient 
mouse, (iv) After an injection of rhodamine-dextran also the blood vessels could be detected 
(displayed in red). The dimensions of the original Z-Stack were: x = 227.36 |im and y = 227.36 
|im; z = 92 |im. Image resolution (XYZ) was 512 x 512 x 28 |im. One pixel in x and y are 
equivalent to 0,445 |im and in z= 4 |im. (G) Trans-stromal migration of WT HSC/P through non-
irradiated WT or Cx43-deficient stromal cells. Empty bars represent control (WT) values and 
solid bars represent OB/P Cx43-deficient values. Data are shown as mean ± SEM (*p<0.05; **p 
<0.01). 
Figure 5. Cxc12 expression and secretion are increased in OB/P Cx43-deficient BM. (A, 
C) Western Blot of whole BM lysates analyzed for Cxcl12 expression basally (A) and after G-
CSF administration (C). (B, D) Extracellular BM Cxcl12 levels determined by ELISA in WT and 
OB/P Cx43-deficient BM from steady-state and lethally irradiated mice (16 hours post-
irradiation) (B) and in non-myeloablated mice after G-CSF administration (D). Empty bars 
represent control (WT) values and solid bars represent OB/P Cx43-deficient values. Data are 
shown as mean ± SEM of 3 independent experiments with a minimum of 5 mice per group 
(*p<0.05;**p<0.01). 
Figure 6. Cx43 regulates the cellular composition in non-myeloablated BM. (A-B) Content 
of BM mesenchymal (CFU-F) (A) and osteoblastic progenitors (CFU-OB) (B) in BM of WT and 
OB/P Cx43-deficient mice. (C-E) Quantification of immunophenotypically identified non 
hematopoietic cells (C) and Cadherin-11 negative (D) or positive (E) subpopulations. (F-G) 
OB/P-Cx43-deficient mice showed an increased number of Cxcl12+ cells among both CD45" 
/Ter1197cadherin-11+ and CD457Ter1197cadherin-1T cell subpopulations. (H) Representative 
example of flow cytometry analysis of BrdU+ cells on different mesenchymal cell 
subpopulations. (I) In vivo proliferation of BM CD457Ter119" and Cxcl12+ mesenchymal cells. 
(J) Normalized RNA expression of sclerostin in cortical bones from WT or OB/P Cx43-deficient 
mice. Results for sclerostin expression are presented as average of 2 mice per group where 
expression was analyzed in femora, tibiae and pelvic cortical bones. Empty bars present control 
data; solid bars represent data from OB/P Cx43 deficient mice. Analysis of OB/P populations 
are shown as mean ± SD. N=3 different experiments n=6 mice per group (* p<0.05; ** p<0.01). 
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